FDA's Woodcock on New Unit to Boost Drug Oversight

REPLAY VIDEO
Your next video will start in
Pause
  • Info

  • Comments

Feb. 14 (Bloomberg) -- Janet Woodcock, director of the U.S. Food and Drug Administration's Center for Drug Evaluation and Research, speaks about the agency's decision to form a new unit to improve the FDA's scrutiny of brand-name, generic and over-the-counter drugs. Woodcock speaks at the Bloomberg 2014 State of Health Care summit in New York. (Source: Bloomberg)

Advertisement

BTV Channel Finder

Channel_finder_loader

ZIP is required for U.S. locations

Bloomberg Television in   change